Search Results - "Baggott, MJ"

Buprenorphine and naloxone interactions in opiate-dependent volunteers by Mendelson, J, Jones, R T, Fernandez, I, Welm, S, Melby, A K, Baggott, M J

“…Sublingual buprenorphine appears useful in the treatment of opiate dependence. A combination sublingual dose of buprenorphine and naloxone could have less…”
Get more information

A Randomized, Placebo-Controlled Trial of Sustained-Release Dextroamphetamine for Treatment of Methamphetamine Addiction by Galloway, GP, Buscemi, R, Coyle, JR, Flower, K, Siegrist, JD, Fiske, LA, Baggott, MJ, Li, L, Polcin, D, Chen, CYA, Mendelson, J

“…Sixty treatment‐seeking individuals with methamphetamine (MA) dependence entered a randomized, placebo‐controlled, double‐blind clinical trial of oral…”
Get full text

Mechanisms and Genetics of Antipsychotic-Associated Weight Gain by Balt, SL, Galloway, GP, Baggott, MJ, Schwartz, Z, Mendelson, J

“…Antipsychotic medications, which comprise one of the most widely prescribed medication classes, have proven effective in many psychiatric conditions. However,…”
Get full text

Preventing Problems in Ecstasy Users: Reduce Use to Reduce Harm by Baggott, Matthew J.

“…Increasing use of 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") has been accompanied by concern about acute and possible long-term toxicity. This article…”
Get full text

A high-dose methamphetamine regimen results in long-lasting deficits on performance of a reaction-time task by Richards, J B, Baggott, M J, Sabol, K E, Seiden, L S

“…Rats were treated with a high-dose methamphetamine (METH) regimen (50 mg/kg 3 times at 8-h intervals). Three weeks after treatment, they were trained on a…”
Get more information

Doubling up by Baggott, Matthew J

“…A letter to the editor commends "New Scientist" for its review of discrepancies in the politicized field of Ecstasy research…”
Get full text